ClinicalTrials.Veeva

Menu

The Role of the FTO Gene in Reward System Activation in Obese and Healthy Subjects

U

Uppsala University

Status

Unknown

Conditions

Eating Behavior
Obesity

Treatments

Procedure: Blood sampling for genetic analyse
Behavioral: Stroop test
Other: fMRI

Study type

Interventional

Funder types

Other

Identifiers

NCT01863212
LSF008786

Details and patient eligibility

About

In order to investigate if individuals, carrying genetic variants predisposing to obesity, respond differently to visual presented food images than non-carriers the investigators aim to screen 500 people for a common risk variant in the FTO gene. From those 500 screened 40 subjects, 20 homozygous for the risk allele and 20 homozygous for a non risk allele will be selected for the second step in the study. This part involves the fMRI technique to visualize the brain response, focus on reward system activation, when food images are visually presented in the scanner. Factors regarding eating behavior, sleep, physical exercise and relation to food are investigated in the first part of the study as well as clinical parameters such as BMI.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 37 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • No medications (except contraceptives including estrogen)
  • No metabolic disorders/diseases
  • Right handed
  • Color vision
  • Normal sleep-wake rhythm (eg. shift workers can not participate)

Exclusion criteria

  • Specific preferences of food, for example vegetarians
  • Grandparents originating from country outside the Nordic area
  • Metallic implants

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

500 participants in 2 patient groups

Risk allele carriers
Experimental group
Description:
Individuals homozygous for the risk allele (A/A) The interventions administrated to this group: 'Blood sampling for genetic analyse', 'Stroop test', 'fMRI'
Treatment:
Behavioral: Stroop test
Procedure: Blood sampling for genetic analyse
Other: fMRI
Non risk allele carriers
Experimental group
Description:
Individuals homozygous for the non-risk allele (T/T) The interventions administrated to this group: 'Blood sampling for genetic analyse', 'Stroop test', 'fMRI'
Treatment:
Behavioral: Stroop test
Procedure: Blood sampling for genetic analyse
Other: fMRI

Trial contacts and locations

2

Loading...

Central trial contact

Christian Benedict, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems